首页 > 最新文献

Wiener Klinische Wochenschrift最新文献

英文 中文
Excessive smartphone use increases self-reported auditory and vestibular symptoms. 过度使用智能手机会增加自我报告的听觉和前庭症状。
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-23 DOI: 10.1007/s00508-024-02418-1
Emre Söylemez, Mehmet Dağ, Abdulkadir Ilgaz, Bekir Korkmaz, Ümit Topçuoğlu, Ahmet Düha Koç, Serdar Ensari

Background: With widespread smartphone use, there is growing concern about their potential impact on human health.

Objective: The effects of smartphone use on self-reported hearing ability, tinnitus, balance, falls, and anxiety level were investigated in this study.

Methods: This study included 682 participants who were divided into 2 groups: a high smartphone use (HSU) group and a low smartphone use (LSU) group. Both groups were evaluated for hearing ability using the Amsterdam inventory for auditory disability and handicap; balance status using the vertigo, dizziness, imbalance symptom scale; anxiety status using the Beck anxiety index; and fall and tinnitus status using the visual analog scale.

Results: The HSU group showed significantly worse hearing ability, tinnitus, balance, falling, and anxiety status results than the LSU group (p < 0.001). There was a positive correlation between smartphone addiction severity and auditory impairment, tinnitus, risk of falling, and anxiety, as well as a negative correlation with balance score (p < 0.001).

Conclusion: The findings suggest that individuals with excessive smartphone use are more likely to experience hearing, tinnitus, balance, falling, and anxiety problems than those who use smartphones less frequently. Excessive smartphone use may be considered a potential risk factor for these problems.

背景:随着智能手机的广泛使用,人们越来越关注其对人类健康的潜在影响:随着智能手机的广泛使用,人们越来越关注其对人类健康的潜在影响:本研究调查了使用智能手机对自我报告的听力、耳鸣、平衡、跌倒和焦虑水平的影响:本研究将 682 名参与者分为两组:智能手机使用率高(HSU)组和智能手机使用率低(LSU)组。两组均使用阿姆斯特丹听觉残疾和障碍清单评估听力能力;使用眩晕、头晕、不平衡症状量表评估平衡状况;使用贝克焦虑指数评估焦虑状况;使用视觉模拟量表评估跌倒和耳鸣状况:结果:HSU 组的听力、耳鸣、平衡、跌倒和焦虑状况明显差于 LSU 组(p 结论:HSU 组的听力、耳鸣、平衡、跌倒和焦虑状况明显差于 LSU 组:研究结果表明,与较少使用智能手机的人相比,过度使用智能手机的人更容易出现听力、耳鸣、平衡、跌倒和焦虑问题。过度使用智能手机可被视为导致这些问题的潜在风险因素。
{"title":"Excessive smartphone use increases self-reported auditory and vestibular symptoms.","authors":"Emre Söylemez, Mehmet Dağ, Abdulkadir Ilgaz, Bekir Korkmaz, Ümit Topçuoğlu, Ahmet Düha Koç, Serdar Ensari","doi":"10.1007/s00508-024-02418-1","DOIUrl":"https://doi.org/10.1007/s00508-024-02418-1","url":null,"abstract":"<p><strong>Background: </strong>With widespread smartphone use, there is growing concern about their potential impact on human health.</p><p><strong>Objective: </strong>The effects of smartphone use on self-reported hearing ability, tinnitus, balance, falls, and anxiety level were investigated in this study.</p><p><strong>Methods: </strong>This study included 682 participants who were divided into 2 groups: a high smartphone use (HSU) group and a low smartphone use (LSU) group. Both groups were evaluated for hearing ability using the Amsterdam inventory for auditory disability and handicap; balance status using the vertigo, dizziness, imbalance symptom scale; anxiety status using the Beck anxiety index; and fall and tinnitus status using the visual analog scale.</p><p><strong>Results: </strong>The HSU group showed significantly worse hearing ability, tinnitus, balance, falling, and anxiety status results than the LSU group (p < 0.001). There was a positive correlation between smartphone addiction severity and auditory impairment, tinnitus, risk of falling, and anxiety, as well as a negative correlation with balance score (p < 0.001).</p><p><strong>Conclusion: </strong>The findings suggest that individuals with excessive smartphone use are more likely to experience hearing, tinnitus, balance, falling, and anxiety problems than those who use smartphones less frequently. Excessive smartphone use may be considered a potential risk factor for these problems.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of intradetrusor abobotulinumtoxinA and incobotulinumtoxinA in women with overactive bladder and the value of local anesthesia: a randomized clinical study. 膀胱过度活动症妇女尿道内注射阿博毒素A和incobotulinumtoxinA的疗效和安全性以及局部麻醉的价值:一项随机临床研究。
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-23 DOI: 10.1007/s00508-024-02412-7
Niko Kavcic, Andrej Avsenak, Jan Zmazek, Tamara Serdinsek, Igor But

Background: A non-inferiority clinical study evaluated the efficacy and safety of abobotulinumtoxinA vs. incobotulinumtoxinA intradetrusor injections in women with overactive bladder and urge urinary incontinence. Also, the effect of local anesthesia on the pain level of the procedure was assessed.

Methods: Patients were randomized to receive 20 intradetrusor injections of either 300 U abobotulinumtoxinA or 100 U incobotulinumtoxinA. They were further randomized to receive either local anesthesia (40 ml 1% lidocaine solution) or placebo before botulinum toxin injection. Before the procedure and 4 months after the procedure each patient reported urinary incontinence episodes, frequency, nocturia, completed the Urogenital Distress Inventory (UDI-6) score, Incontinence Impact Questionnaire (IIQ-7), and Incontinence Quality of Life (I-QOL) questionnaire. Each patient completed a patient satisfaction survey 4 months after the procedure. During the procedure, the patients graded the pain intensity of every injection on a visual analog scale (VAS). The total score of each questionnaire was considered.

Results: A total of 54 patients with a mean age of 66 ± 13 (SD) years completed the study. Total scores of UDI‑6, IIQ‑7, I‑QOL, patient satisfaction, urinary incontinence episodes, frequency, nocturia and VAS questionnaires did not show differences between the abobotulinumtoxinA (n = 26) or incobotulinumtoxinA (n = 28) group. Urinary retention requiring catheterization was noted in five patients. The VAS and patient satisfaction questionnaire values did not show significant differences between the group receiving bladder instillation with lidocaine solution (n = 28) or the group receiving placebo (n = 26).

Conclusion: In women with overactive bladder and urge urinary incontinence where conservative treatment failed, abobotulinumtoxinA vs. incobotulinumtoxinA intradetrusor injections showed comparable results regarding improved clinical outcome and patient satisfaction. Local anesthesia before the procedure did not reduce the pain level in comparison with the placebo.

研究背景一项非劣效性临床研究评估了在膀胱过度活动症和急迫性尿失禁女性患者中进行abobotulinumtoxinA与incobotulinumtoxinA尿道内注射的疗效和安全性。此外,还评估了局部麻醉对手术疼痛程度的影响:方法:患者被随机分配接受20次300 U阿博妥珠单抗或100 U伊科妥珠单抗的尿道内注射。在注射肉毒杆菌毒素前,他们还被随机分配接受局部麻醉(40 毫升 1%利多卡因溶液)或安慰剂。术前和术后4个月,每位患者都报告了尿失禁发作次数、频率和夜尿情况,并填写了尿道窘迫量表(UDI-6)评分、尿失禁影响问卷(IIQ-7)和尿失禁生活质量(I-QOL)问卷。每位患者都在手术后 4 个月完成了患者满意度调查。在手术过程中,患者用视觉模拟量表(VAS)对每次注射的疼痛强度进行评分。每份问卷的总分均被考虑在内:共有 54 名患者完成了研究,平均年龄为 66 ± 13(标清)岁。UDI-6、IIQ-7、I-QOL、患者满意度、尿失禁次数、尿频、夜尿和VAS问卷的总分在阿博毒素组(26人)和非阿博毒素组(28人)之间没有差异。有五名患者出现尿潴留,需要导尿。接受利多卡因溶液膀胱灌注治疗组(28 人)和接受安慰剂治疗组(26 人)的 VAS 值和患者满意度问卷值没有明显差异:结论:对于保守治疗失败的膀胱过度活动症和急迫性尿失禁女性患者,在改善临床疗效和提高患者满意度方面,阿博妥珠单抗与伊可丁单抗尿道内注射效果相当。与安慰剂相比,手术前局部麻醉并不能减轻疼痛程度。
{"title":"Efficacy and safety of intradetrusor abobotulinumtoxinA and incobotulinumtoxinA in women with overactive bladder and the value of local anesthesia: a randomized clinical study.","authors":"Niko Kavcic, Andrej Avsenak, Jan Zmazek, Tamara Serdinsek, Igor But","doi":"10.1007/s00508-024-02412-7","DOIUrl":"https://doi.org/10.1007/s00508-024-02412-7","url":null,"abstract":"<p><strong>Background: </strong>A non-inferiority clinical study evaluated the efficacy and safety of abobotulinumtoxinA vs. incobotulinumtoxinA intradetrusor injections in women with overactive bladder and urge urinary incontinence. Also, the effect of local anesthesia on the pain level of the procedure was assessed.</p><p><strong>Methods: </strong>Patients were randomized to receive 20 intradetrusor injections of either 300 U abobotulinumtoxinA or 100 U incobotulinumtoxinA. They were further randomized to receive either local anesthesia (40 ml 1% lidocaine solution) or placebo before botulinum toxin injection. Before the procedure and 4 months after the procedure each patient reported urinary incontinence episodes, frequency, nocturia, completed the Urogenital Distress Inventory (UDI-6) score, Incontinence Impact Questionnaire (IIQ-7), and Incontinence Quality of Life (I-QOL) questionnaire. Each patient completed a patient satisfaction survey 4 months after the procedure. During the procedure, the patients graded the pain intensity of every injection on a visual analog scale (VAS). The total score of each questionnaire was considered.</p><p><strong>Results: </strong>A total of 54 patients with a mean age of 66 ± 13 (SD) years completed the study. Total scores of UDI‑6, IIQ‑7, I‑QOL, patient satisfaction, urinary incontinence episodes, frequency, nocturia and VAS questionnaires did not show differences between the abobotulinumtoxinA (n = 26) or incobotulinumtoxinA (n = 28) group. Urinary retention requiring catheterization was noted in five patients. The VAS and patient satisfaction questionnaire values did not show significant differences between the group receiving bladder instillation with lidocaine solution (n = 28) or the group receiving placebo (n = 26).</p><p><strong>Conclusion: </strong>In women with overactive bladder and urge urinary incontinence where conservative treatment failed, abobotulinumtoxinA vs. incobotulinumtoxinA intradetrusor injections showed comparable results regarding improved clinical outcome and patient satisfaction. Local anesthesia before the procedure did not reduce the pain level in comparison with the placebo.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142047279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isolated pulmonary valve endocarditis. 孤立性肺动脉瓣心内膜炎。
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-23 DOI: 10.1007/s00508-024-02416-3
Sonja Valsky, David Mutschlechner, Dominik Wiedemann, Thomas Gremmel

Isolated pulmonary valve endocarditis (IPE) is a rare form of infectious endocarditis. This article reports the case of a 49-year-old patient with IPE who was initially admitted with suspected cholecystitis. After vegetations were detected by transthoracic (TTE) and transesophageal echocardiography (TEE), antibiotic therapy in accordance with the antibiogram was primarily attempted; however, due to persistently elevated infection parameters and structural valve damage a pulmonary valve replacement was eventually performed.

孤立性肺动脉瓣心内膜炎(IPE)是一种罕见的感染性心内膜炎。本文报告了一名 49 岁 IPE 患者的病例,该患者最初入院时被怀疑患有胆囊炎。在经胸超声心动图(TTE)和经食道超声心动图(TEE)检测出植物瓣后,主要尝试根据抗生素图谱进行抗生素治疗;然而,由于感染指标持续升高和结构性瓣膜损伤,最终进行了肺动脉瓣置换术。
{"title":"Isolated pulmonary valve endocarditis.","authors":"Sonja Valsky, David Mutschlechner, Dominik Wiedemann, Thomas Gremmel","doi":"10.1007/s00508-024-02416-3","DOIUrl":"https://doi.org/10.1007/s00508-024-02416-3","url":null,"abstract":"<p><p>Isolated pulmonary valve endocarditis (IPE) is a rare form of infectious endocarditis. This article reports the case of a 49-year-old patient with IPE who was initially admitted with suspected cholecystitis. After vegetations were detected by transthoracic (TTE) and transesophageal echocardiography (TEE), antibiotic therapy in accordance with the antibiogram was primarily attempted; however, due to persistently elevated infection parameters and structural valve damage a pulmonary valve replacement was eventually performed.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142047280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Train Climbing-A new old trend in adolescents: Treatment of high voltage injuries and planning of a pilot project to raise awareness. 爬火车--青少年的新潮流:高压电伤的治疗和提高认识试点项目的规划。
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-22 DOI: 10.1007/s00508-024-02399-1
Viktoria Koenig, Philipp Tratnig-Frankl, Anna Pittermann, Marita Windpassinger, Julian Joestl, Oskar Aszmann

Introduction: An increasing number of high voltage electric burn injuries in a typically younger patient collective of train surfers and climbers at our level I center for burns was recognized. The purpose of this study was a retrospective data evaluation and as a consequence the implementation of an awareness program against train surfing.

Material and methods: In a retrospective analysis of prospectively collected data, 17 patients with high voltage injuries, who had been treated at our unit between January 2022 and January 2023, were identified. Of these patients seven were treated for injuries due to train surfing or climbing and therefore included in this study. The patients were assessed clinically for total burn surface area (TBSA), degree of burn, associated Injuries, hospital length of stay, number and type of surgeries (fasciotomy, minor/major amputations, defect coverage split skin graft or flaps).

Results: A total of seven males formed the basis of this report with an average age of 17.7 years (range 14-21 years). The highest ABSI (Abbreviated Burn Severity Index) score was 12, leading to the death of the 21-year-old patient who had 80% TBSA as well as multiple comorbidities including severe brain damage. The mean duration of stay at the intensive care unit (ICU) was 24.8 days and the mortality rate was 14.29%.

Conclusion: This study highlighted the severity of injuries, with a mean TBSA of 41.42% and a mortality rate of 14.29% among the study population. Train climbing and surfing patients presented with severe injuries and fatal long-term consequences. A pilot project involving several stakeholders was initiated in order to raise awareness of the dangers of electric arcs and the risk involved.

导言:我们的一级烧伤中心发现,在典型的年轻患者群体中,火车冲浪者和登山者的高压电烧伤数量不断增加。本研究的目的是对数据进行回顾性评估,并由此实施一项针对火车冲浪的宣传计划:通过对前瞻性收集的数据进行回顾性分析,确定了 2022 年 1 月至 2023 年 1 月期间在本中心接受治疗的 17 名高压电伤患者。其中七名患者因火车冲浪或登山受伤而接受治疗,因此被纳入本研究。对患者的烧伤总面积(TBSA)、烧伤程度、相关损伤、住院时间、手术次数和类型(筋膜切开术、小/大截肢、缺损覆盖分层植皮或皮瓣)进行了临床评估:本报告共涉及七名男性患者,平均年龄为 17.7 岁(14-21 岁不等)。烧伤严重程度指数(ABSI)最高分为 12 分,其中一名 21 岁的患者因烧伤面积达 80%、合并多种疾病(包括严重脑损伤)而死亡。患者在重症监护室的平均住院时间为 24.8 天,死亡率为 14.29%:这项研究强调了受伤的严重性,研究对象的平均总脑损伤面积为 41.42%,死亡率为 14.29%。火车攀爬和冲浪患者受伤严重,长期后果致命。为了提高人们对电弧危险性和所涉风险的认识,启动了一个由多个利益相关方参与的试点项目。
{"title":"Train Climbing-A new old trend in adolescents: Treatment of high voltage injuries and planning of a pilot project to raise awareness.","authors":"Viktoria Koenig, Philipp Tratnig-Frankl, Anna Pittermann, Marita Windpassinger, Julian Joestl, Oskar Aszmann","doi":"10.1007/s00508-024-02399-1","DOIUrl":"https://doi.org/10.1007/s00508-024-02399-1","url":null,"abstract":"<p><strong>Introduction: </strong>An increasing number of high voltage electric burn injuries in a typically younger patient collective of train surfers and climbers at our level I center for burns was recognized. The purpose of this study was a retrospective data evaluation and as a consequence the implementation of an awareness program against train surfing.</p><p><strong>Material and methods: </strong>In a retrospective analysis of prospectively collected data, 17 patients with high voltage injuries, who had been treated at our unit between January 2022 and January 2023, were identified. Of these patients seven were treated for injuries due to train surfing or climbing and therefore included in this study. The patients were assessed clinically for total burn surface area (TBSA), degree of burn, associated Injuries, hospital length of stay, number and type of surgeries (fasciotomy, minor/major amputations, defect coverage split skin graft or flaps).</p><p><strong>Results: </strong>A total of seven males formed the basis of this report with an average age of 17.7 years (range 14-21 years). The highest ABSI (Abbreviated Burn Severity Index) score was 12, leading to the death of the 21-year-old patient who had 80% TBSA as well as multiple comorbidities including severe brain damage. The mean duration of stay at the intensive care unit (ICU) was 24.8 days and the mortality rate was 14.29%.</p><p><strong>Conclusion: </strong>This study highlighted the severity of injuries, with a mean TBSA of 41.42% and a mortality rate of 14.29% among the study population. Train climbing and surfing patients presented with severe injuries and fatal long-term consequences. A pilot project involving several stakeholders was initiated in order to raise awareness of the dangers of electric arcs and the risk involved.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142018858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PCSK9 inhibitors in real life-Cardiometabolic risk management in dyslipidemic patients in Vienna. 现实生活中的 PCSK9 抑制剂--维也纳血脂异常患者的心脏代谢风险管理。
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-13 DOI: 10.1007/s00508-024-02402-9
M Ferch, C Sert, P Fellinger, A Kautzky-Willer, Y Winhofer-Stöckl

Background: Proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors have emerged as important therapeutic options for patients unable to achieve the low-density lipoprotein cholesterol (LDL‑C) target or to tolerate alternative lipid-lowering agents. The aim of this study was to investigate the efficacy of PCSK9 inhibitor treatment in tertiary routine care, by determining the percentage of patients reaching individual LDL‑C target levels 1 year after treatment initiation.

Patients and methods: Patients routinely started on PCSK9 inhibitors at our lipid clinic between 2017 and 2020 were retrospectively analyzed. Attainment of the LDL‑C target, utilization of follow-ups, cardiovascular events and effects on laboratory parameters were investigated.

Results: In this study 347 patients were included, with the majority managed in secondary prevention (94.5%). The LDL‑C target was achieved by 44.9% after ca. 14 months, with differences between statin users and non-users (51.0% vs. 22.7%; p < 0.001). The median LDL‑C decreased from 126.00 mg/dL at baseline to 48 mg/dL (-61.6%; -77.00 mg/dL; p < 0.001) after ~2 months and to 60 mg/dL (-52.9%; -59.00 mg/dL; p < 0.001) after ~14 months. Median lipoprotein(a) levels decreased significantly from 184.0 nmol/L to 165.5 nmol/L (-25.9%; -25.5 nmol/L; p = 0.001) after ~2 months, whereas no effects on creatine kinase, amylase and lipase were detectable. Of the patients 15% utilized 4 follow-ups. The PCSK9 inhibitor intolerance occurred in 3.5% of patients.

Conclusion: With the effect of LDL-lowering remaining constant over 14 months, PCSK9 inhibitor treatment showed effective and sustainable LDL‑C lowering in a majority of patients in secondary prevention, bringing them closer to the recommended LDL‑C goal, particularly those under concomitant statin medication. Treatment with PCSK9 inhibitors appears to be well-tolerated, confirming data from clinical trials in real life.

背景:对于无法达到低密度脂蛋白胆固醇(LDL-C)目标值或无法耐受其他降脂药物的患者,前蛋白转化酶枯草酶克毒素9型(PCSK9)抑制剂已成为重要的治疗选择。本研究的目的是调查 PCSK9 抑制剂治疗在三级常规治疗中的疗效,确定在开始治疗 1 年后达到个人 LDL-C 目标水平的患者比例:回顾性分析了2017年至2020年间在我院血脂门诊常规开始使用PCSK9抑制剂的患者。调查了低密度脂蛋白胆固醇(LDL-C)目标的实现情况、随访利用率、心血管事件以及对实验室参数的影响:本研究共纳入 347 名患者,其中大部分为二级预防患者(94.5%)。44.9%的患者在约 14 个月后达到了低密度脂蛋白胆固醇目标值。14个月后,44.9%的患者达到了低密度脂蛋白胆固醇目标值,他汀类药物使用者和非使用者之间存在差异(51.0% 对 22.7%;P随着降低低密度脂蛋白的效果在14个月内保持不变,PCSK9抑制剂治疗对大多数二级预防患者的低密度脂蛋白胆固醇降低效果显著且可持续,使他们更接近建议的低密度脂蛋白胆固醇目标,尤其是那些同时服用他汀类药物的患者。PCSK9抑制剂的治疗耐受性似乎很好,证实了临床试验数据在现实生活中的应用。
{"title":"PCSK9 inhibitors in real life-Cardiometabolic risk management in dyslipidemic patients in Vienna.","authors":"M Ferch, C Sert, P Fellinger, A Kautzky-Willer, Y Winhofer-Stöckl","doi":"10.1007/s00508-024-02402-9","DOIUrl":"https://doi.org/10.1007/s00508-024-02402-9","url":null,"abstract":"<p><strong>Background: </strong>Proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors have emerged as important therapeutic options for patients unable to achieve the low-density lipoprotein cholesterol (LDL‑C) target or to tolerate alternative lipid-lowering agents. The aim of this study was to investigate the efficacy of PCSK9 inhibitor treatment in tertiary routine care, by determining the percentage of patients reaching individual LDL‑C target levels 1 year after treatment initiation.</p><p><strong>Patients and methods: </strong>Patients routinely started on PCSK9 inhibitors at our lipid clinic between 2017 and 2020 were retrospectively analyzed. Attainment of the LDL‑C target, utilization of follow-ups, cardiovascular events and effects on laboratory parameters were investigated.</p><p><strong>Results: </strong>In this study 347 patients were included, with the majority managed in secondary prevention (94.5%). The LDL‑C target was achieved by 44.9% after ca. 14 months, with differences between statin users and non-users (51.0% vs. 22.7%; p < 0.001). The median LDL‑C decreased from 126.00 mg/dL at baseline to 48 mg/dL (-61.6%; -77.00 mg/dL; p < 0.001) after ~2 months and to 60 mg/dL (-52.9%; -59.00 mg/dL; p < 0.001) after ~14 months. Median lipoprotein(a) levels decreased significantly from 184.0 nmol/L to 165.5 nmol/L (-25.9%; -25.5 nmol/L; p = 0.001) after ~2 months, whereas no effects on creatine kinase, amylase and lipase were detectable. Of the patients 15% utilized 4 follow-ups. The PCSK9 inhibitor intolerance occurred in 3.5% of patients.</p><p><strong>Conclusion: </strong>With the effect of LDL-lowering remaining constant over 14 months, PCSK9 inhibitor treatment showed effective and sustainable LDL‑C lowering in a majority of patients in secondary prevention, bringing them closer to the recommended LDL‑C goal, particularly those under concomitant statin medication. Treatment with PCSK9 inhibitors appears to be well-tolerated, confirming data from clinical trials in real life.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141971988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing healthcare vulnerabilities in nursing homes : Insights from human rights monitoring in two Austrian provinces. 解决养老院医疗保健方面的薄弱环节:奥地利两个省份人权监测工作的启示。
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-09 DOI: 10.1007/s00508-024-02409-2
Arkadiusz Komorowski, Theresa Rahel Demmer, Marianne Auer, Marianne Schulze, Gabriele Fischer

Background: Current demographic changes bear challenges for national care systems due to higher life expectancy of older citizens. Largely cut off from society, nursing home residents are at risk for violence, neglect, and other potential human rights violations. This study aimed to investigate healthcare vulnerabilities in nursing homes and evaluate the Austrian National Preventive Mechanism (NPM).

Methods: Between 2017 and 2019, 55 monitoring visits were conducted in 32 nursing homes. Study outcomes from two Austrian provinces included data on infrastructure, occupancy, staffing, resident's demographics and medical conditions, as well as measures related to the functioning of the NPM.

Results: Accessibility with mobility aids was sufficient in 87%, but assistance for persons with visual or hearing impairments solely in 20-40% of the institutions. An understaffing with nursing assistants (-5.2 full-time equivalents in Carinthia) and home helpers (-1.6 in Carinthia and Styria) was present. Less than 20% of the personnel received advanced training related to dementia and neuropsychiatric care. While 50% of the residents were diagnosed with a psychiatric disorder, approximately 36% received support from an appointed legal guardian. Of the monitoring visits 58.1% were conducted due to anonymous complaints and urgent referrals. The median processing times of the NPM and the provincial governments exceeded 250 days.

Conclusion: Human rights monitoring reveals critical aspects in nursing home care, including insufficient accessibility, understaffing and inadequate training. Although the authorities' handling times hinder prompt responses, the NPM may foster systemic improvements and accountability within nursing homes.

背景:由于老年公民的预期寿命延长,当前的人口结构变化给国家护理系统带来了挑战。疗养院的居民基本上与社会隔绝,有可能遭受暴力、忽视和其他潜在的侵犯人权行为。本研究旨在调查养老院的医疗保健漏洞,并评估奥地利国家预防机制(NPM):在 2017 年至 2019 年期间,对 32 家养老院进行了 55 次监测访问。来自奥地利两个省份的研究成果包括基础设施、入住率、人员配备、居民人口统计和医疗条件等方面的数据,以及与国家预防机制运作相关的措施:87%的养老院提供了足够的助行器具,但只有 20-40% 的养老院为视力或听力受损者提供了帮助。护理人员(卡林西亚州为-5.2个全职护理人员)和家政服务人员(卡林西亚州和施蒂里亚州为-1.6个全职家政服务人员)人手不足。只有不到 20% 的工作人员接受过与痴呆症和神经精神病护理相关的高级培训。50%的住院者被诊断患有精神疾病,约36%的住院者得到了指定法定监护人的支持。在监测访问中,58.1% 是由于匿名投诉和紧急转介而进行的。国家预防机制和省政府的处理时间中位数超过 250 天:人权监测揭示了养老院护理中的一些关键问题,包括无障碍环境不足、人员配备不足和培训不足。尽管当局的处理时间妨碍了及时回应,但国家预防机制可以促进养老院内部的系统改进和问责制。
{"title":"Addressing healthcare vulnerabilities in nursing homes : Insights from human rights monitoring in two Austrian provinces.","authors":"Arkadiusz Komorowski, Theresa Rahel Demmer, Marianne Auer, Marianne Schulze, Gabriele Fischer","doi":"10.1007/s00508-024-02409-2","DOIUrl":"https://doi.org/10.1007/s00508-024-02409-2","url":null,"abstract":"<p><strong>Background: </strong>Current demographic changes bear challenges for national care systems due to higher life expectancy of older citizens. Largely cut off from society, nursing home residents are at risk for violence, neglect, and other potential human rights violations. This study aimed to investigate healthcare vulnerabilities in nursing homes and evaluate the Austrian National Preventive Mechanism (NPM).</p><p><strong>Methods: </strong>Between 2017 and 2019, 55 monitoring visits were conducted in 32 nursing homes. Study outcomes from two Austrian provinces included data on infrastructure, occupancy, staffing, resident's demographics and medical conditions, as well as measures related to the functioning of the NPM.</p><p><strong>Results: </strong>Accessibility with mobility aids was sufficient in 87%, but assistance for persons with visual or hearing impairments solely in 20-40% of the institutions. An understaffing with nursing assistants (-5.2 full-time equivalents in Carinthia) and home helpers (-1.6 in Carinthia and Styria) was present. Less than 20% of the personnel received advanced training related to dementia and neuropsychiatric care. While 50% of the residents were diagnosed with a psychiatric disorder, approximately 36% received support from an appointed legal guardian. Of the monitoring visits 58.1% were conducted due to anonymous complaints and urgent referrals. The median processing times of the NPM and the provincial governments exceeded 250 days.</p><p><strong>Conclusion: </strong>Human rights monitoring reveals critical aspects in nursing home care, including insufficient accessibility, understaffing and inadequate training. Although the authorities' handling times hinder prompt responses, the NPM may foster systemic improvements and accountability within nursing homes.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141914142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healing chronic idiopathic eosinophilic pneumonia using mepolizumab alone without corticosteroids. 在不使用皮质类固醇的情况下,仅使用美妥珠单抗治愈慢性特发性嗜酸性粒细胞肺炎。
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-08 DOI: 10.1007/s00508-024-02406-5
Katharina Moritz, Carolina Amelunxen, Michael Bergmann, Florian Vafai-Tabrizi, Georg-Christian Funk

While glucocorticoids remain the standard first-line treatment for chronic idiopathic eosinophilic pneumonia (CIEP), the long-term use is marred by significant side effects. This case study explores the effectiveness of mepolizumab, an anti-interleukin‑5 (IL-5) monoclonal antibody, as a novel corticosteroid-free alternative in treating CIEP. A 50-year-old woman presented with a 3-week history of progressive shortness of breath, dry cough and night sweats. The blood tests showed eosinophilia, and chest radiography identified lung consolidations. The CIEP was confirmed, ruling out other conditions through a detailed clinical and bronchoscopic work-up. The patient declined to be treated with systemic glucocorticoids. Treatment with mepolizumab was remarkable for effectively resolving symptoms and improving radiological findings without any prior or concurrent glucocorticoid therapy. Notably, the patient remained relapse-free over a 2-year follow-up, underscoring mepolizumab's efficacy as a corticosteroid-free treatment for CIEP. This case study calls for further research into anti-IL‑5 treatment of rare respiratory conditions.

虽然糖皮质激素仍是治疗慢性特发性嗜酸性细胞肺炎(CIEP)的标准一线疗法,但长期使用会产生严重的副作用。本病例研究探讨了抗白细胞介素-5(IL-5)单克隆抗体mepolizumab作为不含皮质类固醇的新型替代药物治疗CIEP的有效性。一名 50 岁的女性患者因进行性气短、干咳和盗汗就诊 3 周。血液检查显示嗜酸性粒细胞增多,胸片检查发现肺部有合并症。通过详细的临床和支气管镜检查,排除了其他病症,确诊为 CIEP。患者拒绝接受全身糖皮质激素治疗。在未接受任何糖皮质激素治疗或同时接受糖皮质激素治疗的情况下,使用美泊利珠单抗治疗可有效缓解症状并改善放射学检查结果,效果显著。值得注意的是,该患者在2年的随访中一直没有复发,这突显了mepolizumab作为不使用糖皮质激素治疗CIEP的疗效。本病例研究呼吁进一步研究抗IL-5治疗罕见呼吸系统疾病的方法。
{"title":"Healing chronic idiopathic eosinophilic pneumonia using mepolizumab alone without corticosteroids.","authors":"Katharina Moritz, Carolina Amelunxen, Michael Bergmann, Florian Vafai-Tabrizi, Georg-Christian Funk","doi":"10.1007/s00508-024-02406-5","DOIUrl":"https://doi.org/10.1007/s00508-024-02406-5","url":null,"abstract":"<p><p>While glucocorticoids remain the standard first-line treatment for chronic idiopathic eosinophilic pneumonia (CIEP), the long-term use is marred by significant side effects. This case study explores the effectiveness of mepolizumab, an anti-interleukin‑5 (IL-5) monoclonal antibody, as a novel corticosteroid-free alternative in treating CIEP. A 50-year-old woman presented with a 3-week history of progressive shortness of breath, dry cough and night sweats. The blood tests showed eosinophilia, and chest radiography identified lung consolidations. The CIEP was confirmed, ruling out other conditions through a detailed clinical and bronchoscopic work-up. The patient declined to be treated with systemic glucocorticoids. Treatment with mepolizumab was remarkable for effectively resolving symptoms and improving radiological findings without any prior or concurrent glucocorticoid therapy. Notably, the patient remained relapse-free over a 2-year follow-up, underscoring mepolizumab's efficacy as a corticosteroid-free treatment for CIEP. This case study calls for further research into anti-IL‑5 treatment of rare respiratory conditions.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141903070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular (side) effects of cannabis. 大麻对心血管的(副)影响。
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-07 DOI: 10.1007/s00508-024-02403-8
Julia Mascherbauer
{"title":"Cardiovascular (side) effects of cannabis.","authors":"Julia Mascherbauer","doi":"10.1007/s00508-024-02403-8","DOIUrl":"https://doi.org/10.1007/s00508-024-02403-8","url":null,"abstract":"","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141898382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Balint groups' possible role in self-care and job satisfaction of general practitioners-A qualitative study. Balint 小组在全科医生自我保健和工作满意度方面可能发挥的作用--定性研究。
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-06 DOI: 10.1007/s00508-024-02404-7
Karina Schweiger, Benedikt Hofbaur, Susanne Rabady

Background: Concerns are growing when it comes to the shortage of primary care physicians, therefore it seems necessary to take a closer look at job satisfaction and self-care as one of many influences on career choice. A higher job satisfaction reduces the risk to experience burnout and job-related stress and in addition it will contribute to staying in the profession. The objective of this study is to investigate the impact of regular participation in Balint groups on job satisfaction and self-care among general practitioners.

Methods: Descriptive qualitative study with semi-structured expert interviews of 7 general practitioners. Thematical analysis of data and narrative summary.

Results: A total of 402 coded segments were categorized into 8 main themes and 39 subthemes. Interviewees emphasized changes in self-care and job satisfaction as a result of Balint work and mentioned Balint work as a burnout prophylaxis for themselves. Competences that were learnt or improved through Balint work were described as well as aspects such as feedback and connection with colleagues or professional challenges and difficulties.

Conclusion: The results of the study give rise to the assumption that regular participation in Balint groups might help to improve self-care, resilience, and contribute to job satisfaction. Further research is needed before a general recommendation can be made. Many positive aspects were described by the experts, while no harmful negative influences of Balint work were identified.

背景:人们对初级保健医生短缺的担忧与日俱增,因此似乎有必要对工作满意度和自我保健进行更深入的研究,这是影响职业选择的众多因素之一。较高的工作满意度可降低职业倦怠和工作相关压力的风险,此外,它还有助于继续从事这一职业。本研究旨在调查定期参加巴林特小组对全科医生工作满意度和自我保健的影响:描述性定性研究,对 7 名全科医生进行半结构化专家访谈。对数据进行主题分析和叙述性总结:共有 402 个编码片段被归类为 8 个主主题和 39 个次主题。受访者强调了巴林特工作带来的自理能力和工作满意度的变化,并提到巴林特工作可以预防自己的职业倦怠。受访者介绍了通过巴林特工作学习或提高的能力,以及反馈、与同事的联系或职业挑战和困难等方面:研究结果提出了一个假设,即定期参加巴林特小组活动可能有助于提高自我保健能力和应变能力,并有助于提高工作满意度。在提出一般性建议之前,还需要开展进一步的研究。专家们对巴林特工作的许多积极方面进行了描述,但没有发现有害的负面影响。
{"title":"Balint groups' possible role in self-care and job satisfaction of general practitioners-A qualitative study.","authors":"Karina Schweiger, Benedikt Hofbaur, Susanne Rabady","doi":"10.1007/s00508-024-02404-7","DOIUrl":"https://doi.org/10.1007/s00508-024-02404-7","url":null,"abstract":"<p><strong>Background: </strong>Concerns are growing when it comes to the shortage of primary care physicians, therefore it seems necessary to take a closer look at job satisfaction and self-care as one of many influences on career choice. A higher job satisfaction reduces the risk to experience burnout and job-related stress and in addition it will contribute to staying in the profession. The objective of this study is to investigate the impact of regular participation in Balint groups on job satisfaction and self-care among general practitioners.</p><p><strong>Methods: </strong>Descriptive qualitative study with semi-structured expert interviews of 7 general practitioners. Thematical analysis of data and narrative summary.</p><p><strong>Results: </strong>A total of 402 coded segments were categorized into 8 main themes and 39 subthemes. Interviewees emphasized changes in self-care and job satisfaction as a result of Balint work and mentioned Balint work as a burnout prophylaxis for themselves. Competences that were learnt or improved through Balint work were described as well as aspects such as feedback and connection with colleagues or professional challenges and difficulties.</p><p><strong>Conclusion: </strong>The results of the study give rise to the assumption that regular participation in Balint groups might help to improve self-care, resilience, and contribute to job satisfaction. Further research is needed before a general recommendation can be made. Many positive aspects were described by the experts, while no harmful negative influences of Balint work were identified.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The future of general practice and family medicine in Austria. 奥地利全科医学和家庭医学的未来。
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-06 DOI: 10.1007/s00508-024-02422-5
Susanne Rabady

General practice/family medicine has recently been recognized as a medical discipline in Austria. This paper is a short report on the prevailing understanding of its goals and subjects, comparing the Austrian perception with international definitions. It comments on shortcomings and introduces an outline for the development of a revised professional theory.At present, there is no clear uniform image of the discipline, neither among the general public, nor among physicians, healthcare professionals or decision makers. The reason for this lies in the historical development which, with the triumph of specialization, has led to a loss of importance for generalist medicine. Now it is the fragmentation that extensive specialization entails that gives a new meaning to generalist, contextual and patient-centered medicine.This change needs to be analyzed and understood. A description of the responsibilities, tasks and very specific methods unique to the discipline will be developed, which should enable the sensible, contemporary use of general practice/family medicine for the benefit of patients and the healthcare system.

全科/家庭医学最近在奥地利被确认为一门医学学科。本文是一份简短的报告,介绍了对其目标和科目的普遍认识,并将奥地利的认识与国际定义进行了比较。目前,无论是在公众中,还是在医生、医疗保健专业人员或决策者中,对这门学科都没有一个清晰统一的印象。究其原因,在于历史的发展,随着专业化的胜利,全科医学的重要性逐渐丧失。现在,正是广泛的专业化所带来的碎片化赋予了全科医学、因地制宜医学和以患者为中心医学新的含义。将对该学科特有的责任、任务和非常具体的方法进行描述,这将使全科医学/家庭医学得到合理、现代的利用,从而造福于患者和医疗保健系统。
{"title":"The future of general practice and family medicine in Austria.","authors":"Susanne Rabady","doi":"10.1007/s00508-024-02422-5","DOIUrl":"https://doi.org/10.1007/s00508-024-02422-5","url":null,"abstract":"<p><p>General practice/family medicine has recently been recognized as a medical discipline in Austria. This paper is a short report on the prevailing understanding of its goals and subjects, comparing the Austrian perception with international definitions. It comments on shortcomings and introduces an outline for the development of a revised professional theory.At present, there is no clear uniform image of the discipline, neither among the general public, nor among physicians, healthcare professionals or decision makers. The reason for this lies in the historical development which, with the triumph of specialization, has led to a loss of importance for generalist medicine. Now it is the fragmentation that extensive specialization entails that gives a new meaning to generalist, contextual and patient-centered medicine.This change needs to be analyzed and understood. A description of the responsibilities, tasks and very specific methods unique to the discipline will be developed, which should enable the sensible, contemporary use of general practice/family medicine for the benefit of patients and the healthcare system.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141898383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Wiener Klinische Wochenschrift
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1